✦ LIBER ✦

Second-line chemotherapy in advanced cancer of the pancreas: A multicenter survey of the Gruppo Oncologico Italia Meridonale on the activity and safety of the folfiri regimen in clinical practice

✍ Scribed by C. Arcara; E. Maiello; Giuliani; N. Borsellino; V. Gebbia; G. Colucci

Book ID: 119233665
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 67 KB
Volume: 6
Category: Article
ISSN: 1359-6349
DOI: 10.1016/j.ejcsup.2008.06.037

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bevacizumab + folfiri as first

Bevacizumab + folfiri as first-line treatment in advanced colorectal cancer (ACC): A multicenter phase II study of the Gruppo Oncologico dell’ Italia Meridionale (prot. GOIM 2601)

✍ F. Giuliani; V. Lorusso; F. De Vita; S. Cinieri; E. Maiello; I. Nugnes; S. del P 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Second-line chemotherapy with fluorourac

Second-line chemotherapy with fluorouracil, leucovorin, and irinotecan (FOLFIRI regimen) in patients with advanced small bowel adenocarcinoma after failure of first-line platinum-based chemotherapy : A multicenter AGEO study

✍ Aziz Zaanan; Mélanie Gauthier; David Malka; Christophe Locher; Jean-Marc Gornet; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB 👁 1 views

## Abstract ## BACKGROUND: Small bowel adenocarcinoma (SBA) is a rare tumor with poor prognosis. First‐line platinum‐based chemotherapy is active in patients with advanced SBA, but data regarding second‐line chemotherapy are lacking. The aim of this study was to evaluate the efficacy and tolerabil

The efficacy and safety of bevacizumab b

The efficacy and safety of bevacizumab beyond first progression in patients treated with first-line mFOLFOX6 followed by second-line FOLFIRI in advanced colorectal cancer: a multicenter, single-arm, phase II trial (CCOG-0801)

✍ Goro Nakayama, Keisuke Uehara, Kiyoshi Ishigure… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 352 KB